|
1
|
Hawk ET, Limburg PJ and Viner JL:
Epidemiology and prevention of colorectal cancer. Surg Clin North
Am. 82:905–941. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung J: Does fecal occult blood test have
a place for colorectal cancer screening in China in 2006? Am J
Gastroenterol. 101:213–215. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taal BG, Van Tinteren H and Zoetmulder FA:
Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved
survival in stage II and III. Br J Cancer. 85:1437–1443. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Douillard JY, Cunningham D, Roth AD, et
al: Irinotecan combined with fluorouracil compared with
fluorouracil alone as first-line treatment for metastatic
colorectal cancer: a multicentre randomised trial. Lancet.
355:1041–1047. 2000. View Article : Google Scholar
|
|
5
|
Redmond SM, Joncourt F, Buser K, et al:
Assessment of P-glycoprotein, glutathione-based detoxifying enzymes
and O6-alkylguanine-DNA alkyltransferase as potential
indicators of constitutive drug resistance in human colorectal
tumors. Cancer Res. 51:2092–2097. 1991.PubMed/NCBI
|
|
6
|
van den Heuvel-Eibrink MM, Sonneveld P and
Pieters R: The prognostic significance of membrane
transport-associated multidrug resistance (MDR) proteins in
leukemia. Int J Clin Pharmacol Ther. 38:94–110. 2000.PubMed/NCBI
|
|
7
|
Tsuruo T, lida H, Tsukagoshi S, et al:
Overcoming of vincristine resistence in P388 leukemia in vivo and
in vitro through enhanced cytotoxicity of vincristine and
vinblastine by verapamil. Cancer Res. 41:1967–1972. 1981.PubMed/NCBI
|
|
8
|
Gao Z, Fields JZ and Boman BM:
Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug
resistance in multidrug resistant human lung cancer cells.
Anticancer Res. 18:3073–3076. 1998.PubMed/NCBI
|
|
9
|
Xia Z, Zhu Z, Zhang L, et al: Specific
reversal of MDR1/P-gp-dependent multidrug resistance by RNA
interference in colon cancer cells. Oncol Rep. 20:1433–1439.
2008.PubMed/NCBI
|
|
10
|
Todaro M, Francipane MG, Medema JP and
Stassi G: Colon cancer stem cells: promise of targeted therapy.
Gastroenterology. 138:2151–2162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Todaro M, Alea Mp, Di Stefano AB, et al:
Colon cancer stem cells dictate tumor growth and resist cell death
by production of interleukin-4. Cell Stem Cell. 1:389–402. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee CJ, Dosch J and Simeone DM: Pancreatic
cancer stem cells. J Clin Oncol. 26:2806–2812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng X, Shen G, Yang X and Liu W: Most C6
cells are cancer stem cells: evidence from clonal and population
analyses. Cancer Res. 67:3691–3697. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beier D, Hau P, Proescholdt M, et al:
CD133+ and CD133− glioblastoma-derived cancer
stem cells show differential growth characteristics and molecular
profiles. Cancer Res. 67:4010–4015. 2007.PubMed/NCBI
|
|
15
|
Sakariassen PØ, Immervoll H and Chekenya
M: Cancer stem cells as mediators of treatment resistance in brain
tumors: status and controversies. Neoplasia. 9:882–892.
2007.PubMed/NCBI
|
|
16
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, et al: Ovarian cancer side population defines cells with stem
cell-like characteristics and Mullerian Inhibiting Substance
responsiveness. Proc Natl Acad Sci USA. 103:11154–11159. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirschmann-Jax C, Foster AE, Wulf GG, et
al: A distinct ‘side population’ of cells with high drug efflux
capacity in human tumor cells. Proc Natl Acad Sci USA.
101:14228–14233. 2004.
|
|
18
|
Zhou S, Schuetz JD, Bunting KD, et al: The
ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem
cells and is a molecular determinant of the side-population
phenotype. Nat Med. 7:1028–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Behbod F, Xian W, Shaw CA, et al:
Transcriptional profiling of mammary gland side population cells.
Stem Cells. 24:1065–1074. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goodell MA, Brose K, Paradis G, et al:
Isolation and functional propertied of murine hematopoietic stem
cells that are replicating in vivo. J Exp Med. 183:1797–1806. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carmichael J, Degraff WG, Gazdar AF, et
al: Evaluation of a tetrazolium-based semiautomated colorimetric
assay: assessment of chemosensitivity testing. Cancer Res.
47:936–942. 1987.PubMed/NCBI
|
|
22
|
Murase M, Kano M, Tsukahara T, et al: Side
population cells have the characteristics of cancer stem-like
cellscancer-initiating cells in bone sarcomas. Br J Cancer.
101:1425–1432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chiba T, Kita K, Zheng YW, et al: Side
population purified from hepatocellular carcinoma cells harbors
cancer stem cell-like properties. Hepatology. 44:240–251. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitsutake N, Iwao A, Nagai K, et al:
Characterization of side population in thyroid cancer cell lines:
cancer stem-like cells are enriched partly but not exclusively.
Endocrinology. 148:1797–1803. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Guo LP, Chen LZ, et al:
Identification of cancer stem cell-like side population cells in
human nasopharyngeal carcinoma cell line. Cancer Res. 67:3716–3724.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Haraguchi N, Utsunomiya T, Inoue H, et al:
Characterization of a side population of cancer cells from human
gastrointestinal system. Stem Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schetter AJ, Leung SY, Sohn JJ, et al:
MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Callari M, Dugo M, Musella V, et al:
Comparison of microarray platforms for measuring differential
microRNA expression in paired normal/cancer colon tissues. PLoS
One. 7:1–15. 2012. View Article : Google Scholar
|
|
31
|
Inoda S, Hirohashi Y, Torigoe T, et al:
Cytotoxic T lymphocytes efficiently recognize human colon cancer
stem-like cells. Am J Pathol. 178:1805–1813. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Link A, Balaguer F, Shen Y, et al: Fecal
MicroRNAs as novel biomarkers for colon cancer screening. Cancer
Epidemiol Biomarkers Prev. 19:1766–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hofsli E, Sjursen W, Prestvik WS, et al:
Identification of serum microRNA profiles in colon cancer. Br J
Cancer. 108:1712–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Li W, Nan F, et al: MicroRNA
expression profile of colon cancer stem-like cells in HT29
adenocarcinoma cell line. Biochem Biophys Res Commun. 404:273–278.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fang Y, Xiang J, Chen ZY, et al: miRNA
expression profile of colon cancer stem cells compared to non-stem
cells using the SW1116 cell line. Oncol Rep. 28:2115–2124.
2012.PubMed/NCBI
|
